Trial reportBMJ open2026
Can we do better in identifying child developmental conditions early? Sensitivity and specificity of the Watch Me Grow Integrated (WMG-I) digital developmental screening and surveillance tool in Australia.
Trial report in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesWhile child developmental checks are universally recommended, engagement with developmental surveillance programmes is low globally. To address this policy to practice gap, this study examined the diagnostic accuracy of the 'Watch Me Grow' Integrated (WMG-I) digital developmental screening and ongoing surveillance approach.
designThis sub-study examined diagnostic accuracy of the WMG-I digital approach compared with routine assessment (service as usual (SaU)) in a prospective sample. PARTICIPANTS, SETTING AND
interventionParents of 16-to-35-month-old children attending 40 general practices (randomised to WMG-I or SaU) in culturally diverse metropolitan New South Wales and Queensland, Australia, participating in a longitudinal cluster randomised controlled trial. Parents in the WMG-I group completed the WMG-I digital weblink, including a primary screener and automated secondary screener (if concerns were reported). On completion, results and recommendations were transmitted to the parent and general practitioner (GP) allowing discussion and further assessment. This was compared with SaU GP assessment. Once engaged, based on child's date of birth, WMG-I sends automated reminders to take the check again at the next recommended ages, thereby allowing ongoing developmental monitoring/surveillance. PRIMARY OUTCOME MEASURES: All children with identified concerns and a 10% systematic sample without concerns received a reference standard assessment using the Mullen Scale of Early Learning, Autism Diagnostic Observation Schedule and Vineland Adaptive Behaviour Scale. The primary outcome was diagnostic accuracy of WMG-I compared with SAU on the reference standard assessments.
resultsOf the 655 children in the study at age 2 years, 151 children received reference standard assessment. There was a statistically significant difference in the diagnostic accuracy, with 93.9% sensitivity in the WMG-I group (95% CI 88.1% to 99.7%) and 75.9% (95% CI 57.2% to 94%) in the SaU group (p=0.035); specificity was 71.4% (95% CI 54.7% to 88.1%) and 66.7% (95% CI 44.9% to 88.4%) (p=0.743), respectively.
conclusionsUniversal digital surveillance programmes such as WMG-I can enhance time and service efficiency to accurately identify developmental needs. Leveraging routine primary care contact such as immunisation visits to administer WMG-I digital offers a scalable solution for increasing the uptake of developmental surveillance at a population level internationally. TRIAL REGISTRATION NUMBER: ANZCTR12621000680864.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.